Answers are grounded in this paper and cite their sources.
Introduction: Somatic mitochondrial-nuclear DNA transfer (SMNT) is a process by which mitochondrial DNA (mtDNA), of varying sizes, integrate into the nuclear genome and has been previously reported in solid tumours. Methods: EuroClonality-NGS DNA Capture sequencing data from 755 lymphoid malignancies and 59 lymphoid cell lines were analysed for SMNT-associated structural variants. Results: gene disruption identified. Breakpoint features supported non-homologous end joining-mediated integration. Conclusion: SMNTs are rare but recurrent events in lymphoid malignancies and may represent stable clonal markers for minimal residual disease monitoring. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: